Health Care: Drugs

Ophthotech Corp (OPHT: NASDAQ)

$4.5 n/a | n/a%
02/17/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 4.50
52 Week High 65.96
52 Week Low 4.27
Avg. Daily Vol. (Mil) 3.00
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 160.64
Shares Out (Mil) 35.70
Float (Mil) 24.94
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.00
Current Ratio 6.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 3.19
Price/Book 0.00
Price/Cash Flow -1.00
Per Share Data
Earnings -4.62
Sales 1.41
Book Value 0.00
Cash Flow -4.52
Business Summary
Ophthotech Corp is a biopharmaceutical company. The Company is engaged in the development of novel therapeutics to treat diseases of the back of the eye, developing therapeutics for age-related macular degeneration.
General Information
One Penn Plaza, 19th Floor
Suite 1924
New York, NY 10119
Industry : Drugs
Sector: Health Care
Employees: 116
CEO: Dr. David R. Guyer,M.D.
Short Interest
Current Month (Mil) 5.17
Previous Month (Mil) 5.36
Short Interest Ratio (Days) 3.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -46.40
Return on Investments 444.90
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OPHT

Latest OPHT Headlines from TheStreet

More Financial News for OPHT

Press Releases for OPHT

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter